Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
PCSK9 Inhibitors - Market Insight, Epidemiology and Market Forecast – 2032
... as the PCSK9i trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The PCSK9i market report provides emerging drugs, PCSK9i market share of the individual cancer types, current and ... Read More
-
Esketamine DPI Emerging Drug Insight and Market Forecast – 2032
... A detailed picture of the Esketamine DPI for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided ... Read More
-
AXS-05 Emerging Drug Insight and Market Forecast – 2032
... of the AXS-05 for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
Alcohol Use Disorder (AUD) - Market Insight, Epidemiology And Market Forecast - 2032
... and forecasted epidemiology as well as the Alcohol Use Disorder market trends in the United States, the EU-5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The Alcohol Use Disorder market report provides ... Read More
-
APAC Underactive Bladder Market - Industry Trends and Forecast to 2029
... contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029. Market Segmentation Asia-Pacific Underactive Bladder Market, By Treatment (Pharmacotherapy, Surgical Methods, Urethral Assist ... Read More
-
The U.S. Autism Treatment Centers Market: DataPack
... provided by therapists. There are waiting lists, significant untapped demand, and private equity investors are backing new ventures. Franchises are emerging. The incidence of autism among American children has soared from 1 in 150 in ... Read More
-
Europe Underactive Bladder Market - Industry Trends and Forecast to 2029
... contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029. Market Segmentation Europe Underactive Bladder Market, By Treatment (Pharmacotherapy, Surgical Methods, Urethral Assist ... Read More
-
Benralizumab Emerging Drug Insight and Market Forecast − 2032
... of the benralizumab for Chronic Spontaneous Urticaria in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
Cholangiocarcinoma (CCA) - Market Insight, Epidemiology And Market Forecast - 2032
... as the Cholangiocarcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Cholangiocarcinoma market report provides current treatment practices, emerging drugs, cholangiocarcinoma market share of the individual ... Read More
-
ION363 Emerging Drug Insight and Market Forecast – 2032
... the ION363 for Amyotrophic Lateral Sclerosis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with ... Read More
-
Ligelizumab Emerging Drug Insight and Market Forecast − 2032
... of the ligelizumab for Chronic Spontaneous Urticaria in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
LNP023 (Iptacopan) Emerging Drug Insight and Market Forecast – 2032
... detailed picture of the LNP023 (Iptacopan) for Cold Agglutinin Disease in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in ... Read More
-
SPRAVATO Drug Insight and Market Forecast – 2032
... SPRAVATO for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along with a ... Read More
-
Intratumoral Cancer Therapies - Market Insight, Epidemiology And Market Forecast - 2032
... forecasted epidemiology as well as the Intratumoral cancer therapies trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Intratumoral cancer therapies market report provides emerging drugs, Intratumoral cancer ... Read More
-
FASENRA (Benralizumab) Emerging Drug Insight and Market Forecast – 2032
... picture of the FASENRA (Benralizumab) for Nasal Polyposis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report ... Read More
-
REL-1017 Emerging Drug Insight and Market Forecast – 2032
... of the REL-1017 for Treatment Resistant Depression in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this report along ... Read More
-
JAKAFI Drug Insight and Market Forecast – 2032
... Polycythemia Vera in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed description of ... Read More
-
QSYMIA (Phentermine– topiramate), Drug Insight and Market Forecast – 2032
... detailed picture of the QSYMIA (Phentermine– topiramate) for Obesity in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this ... Read More
-
EB05 Emerging Drug Insight and Market Forecast − 2032
... picture of the EB05 for Acute Respiratory Distress Syndrome in 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019 –2032 is provided in this ... Read More
-
Tezepelumab Emerging Drug Insight and Market Forecast – 2032
... Tezepelumab for Nasal Polyposis in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
-
Real World Evidence Solutions Market By Components (Data Sets, Consulting Services), By Application (Market Access and Reimbursement Coverage Decisions, Drug Development and Approvals, Post Market Surveillance, Medical Device Development and Approvals, Others), By End User (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... (Pharmaceutical and Medical Device Companies, Healthcare Payers, Healthcare Providers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global real-world evidence solutions market was valued at $1,369.3 million in 2021, and is projected to reach ... Read More
-
Hidradenitis Suppurativa (HS) - Market Insight, Epidemiology And Market Forecast - 2032
... epidemiology as well as the Hidradenitis Suppurativa market trends in the United States, EU-5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Hidradenitis Suppurativa market report provides current treatment practices, emerging drugs, and market ... Read More
-
Global Next Generation Antibody Therapeutics Market Insights and Forecast to 2028
... 2022, is projected to reach a revised size of US$ 39442.45 million by 2028, growing at a CAGR of 21.51% during the forecast period 2022-2028. The USA market for Next Generation Antibody Therapeutics is estimated ... Read More
-
Federated Learning Market Share, Size, Trends, Industry Analysis Report, By Application (Industrial Internet of Things, Drug Discovery, Risk Management, Augmented and Virtual Reality, Data Privacy Management, Others); By Industry Vertical; By Region; Segment Forecast, 2022 - 2030
... - 2030 The global federated learning market size is expected to reach USD 266.77 million by 2030, according to a new study by Polaris Market Research. The report “Federated Learning Market Share, Size, Trends, Industry ... Read More
-
Rusfertide Emerging Drug Insight and Market Forecast – 2032
... Rusfertide for Polycythemia Vera in the 7MM, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period 2019–2032 is provided in this report along with a detailed ... Read More
Research Assistance
